Gaps In Spiked Supplement Net Could Shrink With Non-Targeted Screening
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to deploy testing technology that casts a wider net than its existing targeted adulterant tests, intending to catch product that may be tainted with as-yet-unknown adulterants.
You may also be interested in...
Labels Offer FDA Clues To Spiked Supplements, Health Fraud
Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.
Labels Offer FDA Clues To Spiked Supplements, Health Fraud
Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.
FDA Proposes Early Detection System For Consumer-Good Contaminants
CFSAN says the program in development would involve a center-wide, coordinated and systematic effort to identify and then move signals about contaminants through a review, management and follow-up process. Ideally, the process would enable FDA and other agencies to respond early to chemical threats.